MedPath

Paracetamol as a Tracer for Plasma Volume Measurements: a Proof of Principle study

Not Applicable
Completed
Conditions
<p>(pre-)eclampsia</p>
10029903
Registration Number
NL-OMON23031
Lead Sponsor
Maastricht UMC+
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
20
Inclusion Criteria

women of at least 18 years of age, (pre-)eclampsia in prior pregnancy, scheduled for PV measurement, agree to participate in the study

Exclusion Criteria

under the age of 18, pregnant, allergy for paracetamol, known to have liver disease which impairs the metabolism of paracetamol, acute liver failure, refusal to participate in the study

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>determination if paracetamol can be used effectively and accurately in determining PV as compared to the gold standard</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>not applicable</p><br>
© Copyright 2025. All Rights Reserved by MedPath